Impact of expanded access to combination antiretroviral therapy in pregnancy: Results from a cohort study in Ukraine;Impact de l'accès élargi au traitement par association d'antirétroviraux pendant la grossesse: Résultats d'une étude de cohorte en Ukraine

Bulletin of the World Health Organization

Volumn 91, Issue 7, 2013, Pages 491-500

  Bailey, Heather ^a   Townsend, Claire L ^b   Semenenko, Igor ^b   Malyuta, Ruslan ^b   Cortina Borja, Mario ^a   Thorne, Claire ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Perinatal Prevention of AIDS Initiative   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

COHORT ANALYSIS; CONFIDENCE INTERVAL; HEALTH CARE; HEALTH POLICY; HUMAN IMMUNODEFICIENCY VIRUS; PREGNANCY; WOMENS HEALTH; WORLD HEALTH ORGANIZATION;

ADULT; ANTIVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; COMBINATION ANTIRETROVIRAL THERAPY; COMBINATION CHEMOTHERAPY; FEMALE; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MONOTHERAPY; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; RISK REDUCTION; UKRAINE; VIRUS TRANSMISSION;

ADULT; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; CONFIDENCE INTERVALS; DRUG THERAPY, COMBINATION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UKRAINE; YOUNG ADULT; ZIDOVUDINE;

UKRAINE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84879572857     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.12.114405     Document Type: Article

References (35)

1. Ukraine harmonized AIDS response progress report. Reporting period: January 2010-December 2011. Kyiv: Ministry of Health; 2012.
2. Hamers FF, Downs AM. HIV in central and eastern Europe. Lancet 2003;361:1035-44. doi: http://dx.doi.org/10.1016/S0140-6736(03)12831-0 PMID:12660072
3. Kruglov YV, Kobyshcha YV, Salyuk T, Varetska O, Shakarishvili A, Saldanha VP. The most severe HIV epidemic in Europe: Ukraine's national HIV prevalence estimates for 2007. Sex Transm Infect 2008;84(Suppl 1):i37-i41. doi: http://dx.doi.org/10.1136/sti.2008.031195 PMID:17804606
4. Lekhan V, Rudiy V, Richardson E. Ukraine: health system review. Health Syst Transit 2010;12:1-183.
5. Comprehensive external evaluation of the national AIDS response in Ukraine: consolidated report. Kyiv: Joint United Nations Programme on HIV/AIDS; 2009.
6. Global price reporting mechanism for HIV, tuberculosis and malaria. [Internet]. Geneva: World Health Organization; 2012. Available from: http://apps.who.int/hiv/amds/price/hdd/Default2.aspx [accessed 3 April 2013].
7. Countdown to zero: global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive, 2011-2015. Geneva: Joint United Nations Programme on HIV/AIDS; 2011. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/20110609_JC2137_Global-Plan-elimination-HIv-Children_en.pdf [accessed 3 April 2013].
8. Antiretroviral drugs for treating pregnant women and preventing HIV infection in their infants: recommendations for a public health approach. Geneva: World Health Organization; 2010.
9. Programmatic update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva: World Health Organization; 2012.
10. Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet 2011;378:282-4. doi: http://dx.doi.org/10.1016/S0140-6736(10)62303-3 PMID:21763940
11. Burruano L, Kruglov Y. HIV/AIDS epidemic in Eastern Europe: recent developments in the Russian Federation and Ukraine among women. Gend Med 2009;6:277-89. doi: http://dx.doi.org/10.1016/j.genm.2009.04.009 PMID:19467524
12. Malyuta R, Newell ML, Ostergren M, Thorne C, Zhilka N. Prevention of mother-to-child transmission of HIV infection: Ukraine experience to date. Eur J Public Health 2006;16:123-7. doi: http://dx.doi.org/10.1093/eurpub/cki150 PMID:16476684
13. Thorne C, Semenenko I, Pilipenko T, Malyuta R; Ukraine European Collaborative Study Group. Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study. BMC Infect Dis 2009;9:40. doi: http://dx.doi.org/10.1186/1471-2334-9-40 PMID:19351387
14. Ukraine: national report on monitoring progress towards the UNGASS Declaration of Commitment on HIV/AIDS, January 2008-December 2009. Kyiv: Ministry of Health; 2010.
15. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach, 2010 revision. Geneva: World Health Organization; 2010.
16. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003;3:21. doi: http://dx.doi.org/10.1186/1471-2288-3-21 PMID:14567763
17. Rabe-Hesketh S, Skrondal A, Pickles A. Reliable estimation of generalised linear mixed models using adaptive quadrature. Stata J 2002;2:1-21.
18. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005;40:458-65. doi: http://dx.doi.org/10.1086/427287 PMID:15668871
19. Liu KC, Mulindwa J, Giganti MJ, Putta NB, Chintu N, Chi BH et al. Predictors of CD4 eligibility for antiretroviral therapy initiation among HIV-infected pregnant women in Lusaka, Zambia. J Acquir Immune Defic Syndr 2011;57:e101-5. doi: http://dx.doi.org/10.1097/QAI.0b013e31821d3507 PMID:21499112
20. Carter RJ, Dugan K, El-Sadr WM, Myer L, Otieno J, Pungpapong N et al. CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings. J Acquir Immune Defic Syndr 2010;55:404-10. doi: http://dx.doi.org/10.1097/QAI.0b013e3181e73f4b PMID:20595905
21. Junghans C, Low N, Chan P, Witschi A, Vernazza P, Egger M. Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study. AIDS 1999;13:2547-54. doi: http://dx.doi.org/10.1097/00002030-199912240-00008 PMID:10630524
22. Wood E, Montaner JS, Chan K, Tyndall MW, Schechter MT, Bangsberg D et al. Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS 2002;16:2065-72. doi: http://dx.doi.org/10.1097/00002030-200210180-00012 PMID:12370506
23. Marc LG, Testa MA, Walker AM, Robbins GK, Shafer RW, Anderson NB et al. Educational attainment and response to HAART during initial therapy for HIV-1 infection. J Psychosom Res 2007;63:207-16. doi: http://dx.doi.org/10.1016/j.jpsychores.2007.04.009 PMID:17662759
24. McNaghten AD, Hanson DL, Dworkin MS, Jones JL; Adult/Adolescent Spectrum of HIV Disease Group. Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients. J Acquir Immune Defic Syndr 2003;32:499-505. doi: http://dx.doi.org/10.1097/00126334-200304150-00006 PMID:12679701
25. Giordano TP, White AC Jr, Sajja P, Graviss EA, Arduino RC, Adu-Oppong A et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr 2003;32:399-405. doi: http://dx.doi.org/10.1097/00126334-200304010-00009 PMID:12640198
26. Barker PM, Mphatswe W, Rollins N. Antiretroviral drugs in the cupboard are not enough: the impact of health systems' performance on mother-to-child transmission of HIV. J Acquir Immune Defic Syndr 2011;56:e45-8. doi: http://dx.doi.org/10.1097/QAI.0b013e3181fdbf20 PMID:21084998
27. Ciaranello AL, Perez F, Keatinge J, Park JE, Engelsmann B, Maruva M et al. What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis. PLoS Med 2012;9:e1001156. doi: http://dx.doi.org/10.1371/journal.pmed.1001156 PMID:22253579
28. Mahy M, Stover J, Kiragu K, Hayashi C, Akwara P, Luo C et al. What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect 2010;86(Suppl 2):ii48-55. doi: http://dx.doi.org/10.1136/sti.2010.045989 PMID:21106515
29. Sterne JA, Hernán MA, Ledergerber B, Tilling K, Weber R, Sendi P et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005;366:378-84. doi: http://dx.doi.org/10.1016/S0140-6736(05)67022-5 PMID:16054937
30. Kuhn L, Kasonde P, Sinkala M, Kankasa C, Semrau K, Scott N et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis 2005;41:1654-61. doi: http://dx.doi.org/10.1086/498029 PMID:16267740
31. Marinda E, Humphrey JH, Iliff PJ, Mutasa K, Nathoo KJ, Piwoz EG et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007;26:519-26. doi: http://dx.doi.org/10.1097/01.inf.0000264527.69954.4c PMID:17529870
32. Thorne C, Semenenko I, Malyuta R; Ukraine European Collaborative Study Group in EuroCoord. Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000-10. Addiction 2012;107:118-28. doi: http://dx.doi.org/10.1111/j.1360-0443.2011.03609.x PMID:21819473
33. Kissin DM, Mandel MG, Akatova N, Belyakov NA, Rakhmanova AG, Voronin EE et al. Five-year trends in epidemiology and prevention of mother-to-child HIV transmission, St. Petersburg, Russia: results from perinatal HIV surveillance. BMC Infect Dis 2011;11:292. doi: http://dx.doi.org/10.1186/1471-2334-11-292 PMID:22032196
34. Bailey H, Thorne C, Semenenko I, Malyuta R, Tereschenko R, Adeyanova I et al. Cervical screening within HIV care: findings from an HIV-positive cohort in Ukraine. PLoS One 2012;7:e34706. doi: http://dx.doi.org/10.1097/01.inf.0000264527.69954.4c PMID:17529870
35. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505. doi: http://dx.doi.org/10.1056/NEJMoa1105243 PMID:21767103